Trillium Asset Management LLC decreased its position in Xylem Inc. (NYSE:XYL) by 2.8% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 360,840 shares of the industrial products company’s stock after selling 10,432 shares during the quarter. Xylem makes up 1.5% of Trillium Asset Management LLC’s portfolio, making the stock its 9th biggest holding. Trillium Asset Management LLC’s holdings in Xylem were worth $27,756,000 at the end of the most recent quarter.
A number of other hedge funds have also recently bought and sold shares of XYL. Fulcrum Capital LLC raised its stake in shares of Xylem by 1.2% in the first quarter. Fulcrum Capital LLC now owns 62,842 shares of the industrial products company’s stock worth $4,834,000 after buying an additional 720 shares during the period. Greenleaf Trust raised its stake in shares of Xylem by 97.4% in the fourth quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock worth $102,000 after buying an additional 735 shares during the period. Barings LLC raised its stake in shares of Xylem by 16.5% in the fourth quarter. Barings LLC now owns 5,656 shares of the industrial products company’s stock worth $386,000 after buying an additional 800 shares during the period. Independent Investors Inc. raised its stake in shares of Xylem by 9.2% in the first quarter. Independent Investors Inc. now owns 9,470 shares of the industrial products company’s stock worth $728,000 after buying an additional 800 shares during the period. Finally, Putnam FL Investment Management Co. raised its stake in shares of Xylem by 0.7% in the fourth quarter. Putnam FL Investment Management Co. now owns 120,448 shares of the industrial products company’s stock worth $8,215,000 after buying an additional 856 shares during the period. 83.09% of the stock is currently owned by institutional investors.
Several research firms have recently commented on XYL. Zacks Investment Research raised Xylem from a “hold” rating to a “buy” rating and set a $88.00 price objective on the stock in a research note on Tuesday, March 20th. Oppenheimer raised their price objective on Xylem to $82.00 and gave the stock an “outperform” rating in a research note on Friday, February 2nd. BMO Capital Markets reaffirmed a “buy” rating and issued a $86.00 price objective on shares of Xylem in a research note on Friday, February 2nd. Seaport Global Securities reaffirmed a “buy” rating and issued a $83.00 price objective on shares of Xylem in a research note on Friday, February 2nd. Finally, Canaccord Genuity set a $78.00 price objective on Xylem and gave the stock a “hold” rating in a research note on Tuesday, April 24th. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $80.20.
Xylem (NYSE:XYL) last issued its earnings results on Tuesday, May 1st. The industrial products company reported $0.51 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.51. The company had revenue of $1.22 billion for the quarter, compared to the consensus estimate of $1.19 billion. Xylem had a return on equity of 18.31% and a net margin of 7.29%. The firm’s quarterly revenue was up 13.6% on a year-over-year basis. During the same quarter last year, the company earned $0.39 EPS. equities analysts expect that Xylem Inc. will post 2.89 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 21st. Investors of record on Thursday, May 24th will be paid a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 1.17%. The ex-dividend date is Wednesday, May 23rd. Xylem’s dividend payout ratio (DPR) is presently 35.00%.
In other Xylem news, Director Curtis J. Crawford sold 7,500 shares of the firm’s stock in a transaction that occurred on Monday, May 14th. The stock was sold at an average price of $73.39, for a total transaction of $550,425.00. Following the completion of the transaction, the director now owns 41,744 shares in the company, valued at approximately $3,063,592.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Tomas Brannemo sold 1,151 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $76.41, for a total value of $87,947.91. The disclosure for this sale can be found here. Insiders have sold a total of 20,657 shares of company stock worth $1,520,904 in the last three months. 0.81% of the stock is owned by corporate insiders.
Xylem Company Profile
Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.